GlassScriptPhysician profile
Stacey Clasen
NPI 1821042607
$908.90
in general payments reported to CMS, 2019-2025
19 companies · $33.56 in 2025
The $33.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $156 · 2021: $156 · 2022: $189 · 2023: $71.28 · 2024: $84.66 · 2025: $33.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.69 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $111.65 | 2019-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Amgen INC. | $102.05 | 2019-2021 | |
| Pfizer INC. | $100.48 | 2019-2024 | |
| Mylan Pharmaceuticals INC. | $64.11 | 2020-2022 | |
| Medtronic, INC. | $33.56 | 2025 | Truclear |
| Organon LLC | $33.13 | 2022 | |
| Biom'Up France Sas | $29.83 | 2020 | |
| Becton, Dickinson and Company | $26.64 | 2022 | |
| Avion Pharmaceuticals | $26.26 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.61 | 2020 | |
| Smith+Nephew, INC. | $22.25 | 2023 | Stravix Pl |
| Exact Sciences Corporation | $19.78 | 2023 | Cologuard Collection Kit |
| Millicent US INC | $13.88 | 2024 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $13.44 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $13.37 | 2023 | Shingrix, Arexvy |
| Astellas Pharma US INC | $13.24 | 2024 | Veozah |
| Evofem Biosciences, INC. | $13.17 | 2021 | |
| Daiichi Sankyo INC. | $10.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Clasen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.